Yang Y, Zhao J, Mao Y, Lin G, et al. UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing beta-catenin. Breast Cancer Res Treat 2020 Sep 10. pii: 10.1007/s10549-020-05899.
PMID: 32914356